Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183 · cited 1×
“Inflammation can lead to further inflammation through tissue damage and necrosis, making the resolution of inflammation even more critical and highlighting the importance of macrophages in this process [62].”
BackgroundTissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063 · cited 1×
“macrophages can still express M1 markers but with lower levels than M1 macrophages, and vice versa [35].”
BackgroundMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980 · cited 7×
“IL-4 and LPS signaling can also target the mechanistic target of rapamycin (mTOR) and Akt to trigger polarization.”
BackgroundInfluentialUnderstanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762 · cited 3×
“Murine M2 macrophages typically express the surface markers Cd206 [17–19,21,22] and Cd163 [23,29] and express/secrete Tgf-β, Pparγ, Ccl14 and Ccl22 [28], and Arg-1 [24,29], similar to human M2 macrophages; however, they also have Chitinase-3-like protein 3 (Chil3), unique from human M2 macrophages (Table 1) [29].”
BackgroundDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581 · cited 1×
“Macrophages also make key hematopoietic decisions by engulfing cells exuded from the bone marrow that do not express the CD47 ligand [9].”
BackgroundMacrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474
Fujiwara, N., & Kobayashi, K. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010054022024 · Cited by 1,420 · cited 9×
“These heterogenous cells originate from monocyte precursors in the blood and differentiate in the presence of cytokines and growth factors in the tissues they infiltrate [2,3].”
BackgroundInfluentialMacrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392 · cited 1×
“This process is spearheaded by M2-type macrophages, which dampen the immune response by secreting anti-inflammatory factors IL-10, TGF-β, and interleukin-1 receptor antagonist (IL-1RA); scavenging debris; and promoting angiogenesis, tissue remodeling, and repair [34,65].”
BackgroundRies, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,306
Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100 · cited 2×
“If this inflammatory macrophage response is not quickly controlled and mediated, it can become pathogenic and lead to disease progression [31,63].”
BackgroundKlug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
Allavena, P., Sica, A., Solinas, G., Porta, C., & Mantovani, A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.07.004 · Cited by 1,044 · cited 5×
“Indirectly, TAMs produce the enzymes plasmin, urokinase plasminogen activator, and MMP, which regulate matrix remodeling and growth factor regulation [5,113].”
BackgroundInfluentialNovel Markers to Delineate Murine M1 and M2 Macrophages
Jablonski, K. A., Amici, S. A., Webb, L. M., Ruiz-Rosado, J. D. D., Popovich, P. G., Partida-Sanchez, S., & Guerau-de-Arellano, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145342 · Cited by 978 · cited 2×
“In humans, M1 macrophages are typically identified by the surface markers CD86 and CD64 [23,24]; the macrophage receptor with collagenous structure MARCO [23,25,26]; C-XC chemokine ligand (CXCL) 9, 10, 11 (CXCL9, 10, 11) [23]; nitric oxide synthase 2 (NOS2), the suppressor of cytokine signaling 1 (SOCS1); and secretio…”
BackgroundVerreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., & Ottenhoff, T. H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400983101 · Cited by 977 · cited 1×
“M1 macrophages are pro-inflammatory in nature and are characterized by their high capacity to present antigens, produce interleukin 12 and 23 (IL-12 and IL-23) [33], and activate type-I T-cell responses [5].”
BackgroundTumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Jetten, N., Verbruggen, S., Gijbels, M. J., Post, M. J., De Winther, M. P. J., & Donners, M. M. P. C. (2014) · Angiogenesis · doi:10.1007/s10456-013-9381-6 · Cited by 839
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Kim, J., & Bae, J.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/6058147 · Cited by 802 · cited 1×
“Neutrophils, specifically tumor-associated neutrophils (TANs), may influence the polarization of macrophages by releasing chemokines and cytokines, functioning to both recruit and polarize monocytes/macrophages in the TME [60].”
BackgroundZhu, Y., Herndon, J. M., Sojka, D. K., Kim, K.-W., Knolhoff, B. L., Zuo, C., Cullinan, D. R., Luo, J., Bearden, A. R., Lavine, K. J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.014 · Cited by 801
Macrophages in inflammation, repair and regeneration
Oishi, Y., & Manabe, I. (2018) · International Immunology · doi:10.1093/intimm/dxy054 · Cited by 734 · cited 4×
“In some genetic diseases such as systemic metabolic dysregulation and muscle dystrophy, the dysfunction of macrophages can lead to worsening conditions such as cancer, atherosclerosis, fibrosis, and other chronic illnesses [8].”
BackgroundInfluentialMolecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins
Holness, C., & Simmons, D. (1993) · Blood · doi:10.1182/blood.v81.6.1607.1607 · Cited by 733
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
Quail, D. F., Bowman, R. L., Akkari, L., Quick, M. L., Schuhmacher, A. J., Huse, J. T., Holland, E. C., Sutton, J. C., & Joyce, J. A. (2016) · Science · doi:10.1126/science.aad3018 · Cited by 666
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Bonapace, L., Coissieux, M.-M., Wyckoff, J., Mertz, K. D., Varga, Z., Junt, T., & Bentires-Alj, M. (2014) · Nature · doi:10.1038/nature13862 · Cited by 665
van de Laar, L., Saelens, W., De Prijck, S., Martens, L., Scott, C. L., Van Isterdael, G., Hoffmann, E., Beyaert, R., Saeys, Y., Lambrecht, B. N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.017 · Cited by 648 · cited 1×
“However, data has suggested that bone marrow-derived macrophages are more susceptible to local signals and subsequent polarization than embryonic macrophages, which appear to exhibit less plasticity than BM-derived macrophages [57].”
BackgroundMazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 621 · cited 5×
“Murine M1 macrophages express macrophage receptors with collagenous structures (Marco) [23,25,26], Cxcl9, Cxcl10, Cxcl11 [23], Nos2, and Socs1, and secrete Il-6, Il-12, Il-1α [27], and Tnf-α [24], all comparable to their human counterparts.”
BackgroundInfluentialPI3K and negative regulation of TLR signaling
Fukao, T., & Koyasu, S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00139-x · Cited by 612 · cited 1×
“NF-κB is a master regulator of M1 activation [41].”
BackgroundTumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Komohara, Y., Fujiwara, Y., Ohnishi, K., & Takeya, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.009 · Cited by 612
Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization
Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E. D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119038109 · Cited by 608 · cited 2×
“In LPS-mediated M1 polarization, Toll-like receptor 4 (TLR4) activates phosphoinositide 3-kinase (PI3K) followed by Akt and mammalian target of rapamycin complex 1 (mTORC1) activation, leading to M1 polarization [39,40].”
BackgroundMacrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Barros, M. H. M., Hauck, F., Dreyer, J. H., Kempkes, B., & Niedobitek, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080908 · Cited by 594
Xu, J., Escamilla, J., Mok, S., David, J., Priceman, S., West, B., Bollag, G., McBride, W., & Wu, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3981 · Cited by 569
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Mitsudomi, T., & Yatabe, Y. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07448.x · Cited by 559
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
Akwii, R. G., Sajib, M. S., Zahra, F. T., & Mikelis, C. M. (2019) · Cells · doi:10.3390/cells8050471 · Cited by 543
Zhang, M., He, Y., Sun, X., Li, Q., Wang, W., Zhao, A., & Di, W. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-19 · Cited by 528
Bain, C. C., Hawley, C. A., Garner, H., Scott, C. L., Schridde, A., Steers, N. J., Mack, M., Joshi, A., Guilliams, M., Mowat, A. M. I., et al. (2016) · Nature Communications · doi:10.1038/ncomms11852 · Cited by 527 · cited 1×
“At any tissue site, there is always a mixture of both bone marrow-derived and embryonic macrophages [55].”
BackgroundPerivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Hughes, R., Qian, B.-Z., Rowan, C., Muthana, M., Keklikoglou, I., Olson, O. C., Tazzyman, S., Danson, S., Addison, C., Clemons, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3587 · Cited by 518
Jaguin, M., Houlbert, N., Fardel, O., & Lecureur, V. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.01.010 · Cited by 518 · cited 3×
“Murine M2 macrophages typically express the surface markers Cd206 [17–19,21,22] and Cd163 [23,29] and express/secrete Tgf-β, Pparγ, Ccl14 and Ccl22 [28], and Arg-1 [24,29], similar to human M2 macrophages; however, they also have Chitinase-3-like protein 3 (Chil3), unique from human M2 macrophages (Table 1) [29].”
BackgroundNakasone, E. S., Askautrud, H. A., Kees, T., Park, J.-H., Plaks, V., Ewald, A. J., Fein, M., Rasch, M. G., Tan, Y.-X., Qiu, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.017 · Cited by 478
Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck, M., & Christofori, G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.06.002 · Cited by 475
Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P., & Kalinski, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2449 · Cited by 464
Bloch, O., Crane, C. A., Kaur, R., Safaee, M., Rutkowski, M. J., & Parsa, A. T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3314 · Cited by 458 · cited 1×
“It was found that CD4 and CD8α T-cell infiltration was significantly increased after tumors were depleted of TAMs [97].”
BackgroundHypoxia Regulates Macrophage Functions in Inflammation
Murdoch, C., Muthana, M., & Lewis, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6257 · Cited by 455
Yeung, O. W. H., Lo, C.-M., Ling, C.-C., Qi, X., Geng, W., Li, C.-X., Ng, K. T. P., Forbes, S. J., Guan, X.-Y., Poon, R. T. P., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.029 · Cited by 453 · cited 3×
“M2 macrophages have a distinct secretory profile responsible for the woundhealing and inflammation-resolving processes, including major roles in extracellular matrix remodeling, angiogenesis, and immune suppression [30].”
BackgroundMa, J., Liu, L., Che, G., Yu, N., Dai, F., & You, Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-112 · Cited by 437 · cited 1×
“Most commonly, M1 macrophages are positively associated with longer survival times and most positive clinical outcomes in many cancers such as small cell lung cancer [79], non-small cell lung cancer [80], colorectal cancer [81], ovarian cancer [77], breast cancer [82], oral squamous cell carcinoma [83], and more.”
BackgroundControl of macrophage metabolism and activation by mTOR and Akt signaling
Covarrubias, A. J., Aksoylar, H. I., & Horng, T. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.08.001 · Cited by 424 · cited 2×
“In LPS-mediated M1 polarization, Toll-like receptor 4 (TLR4) activates phosphoinositide 3-kinase (PI3K) followed by Akt and mammalian target of rapamycin complex 1 (mTORC1) activation, leading to M1 polarization [39,40].”
BackgroundPartners in crime: neutrophils and monocytes/macrophages in inflammation and disease
Prame Kumar, K., Nicholls, A. J., & Wong, C. H. Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2753-2 · Cited by 417 · cited 1×
“Due to the initially highly inflammatory nature of neutrophils, recent evidence has shown that tissue-resident macrophages may adjust to an M2 phenotype to prevent excess inflammation from occurring [61].”
BackgroundInflammation and angiogenesis in osteoarthritis
Haywood, L., McWilliams, D. F., Pearson, C. I., Gill, S. E., Ganesan, A., Wilson, D., & Walsh, D. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11094 · Cited by 395 · cited 1×
“Macrophages have been shown to instruct functional angiogenesis in normal vessel maturation [11], wound healing [12], and development [13] and nonfunctional angiogenesis in many types of cancer [14] and chronic inflammatory conditions [15].”
BackgroundRequirement of DNase II for Definitive Erythropoiesis in the Mouse Fetal Liver
Kawane, K., Fukuyama, H., Kondoh, G., Takeda, J., Ohsawa, Y., Uchiyama, Y., & Nagata, S. (2001) · Science · doi:10.1126/science.292.5521.1546 · Cited by 389 · cited 1×
“Macrophage polarization refers to the activation state of a macrophage at a singular point in time, but due to the plasticity of macrophages, their polarization state is not fixed and can be altered based on the integration of multiple signals from other cells, tissues, and pathogens [32].”
BackgroundAllavena, P., & Mantovani, A. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04515.x · Cited by 384 · cited 17×
“For example, anti-VEGF monoclonal antibody treatment can cause blood vessel damage, inducing hypoxia and stimulating the secretion of myeloid cell chemoattractants [128].”
BackgroundInfluentialRAGE signaling sustains inflammation and promotes tumor development
Gebhardt, C., Riehl, A., Durchdewald, M., Németh, J., Fürstenberger, G., Müller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P. P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070679 · Cited by 379 · cited 1×
“HMGB1 has been shown to be overexpressed in many solid tumors and correlated with the development of hepatocellular carcinoma [47] as well as colon [48] and skin cancers [49].”
BackgroundTorisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., NAKAYAMA, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · PubMed · Cited by 363
A Transgenic Mouse Model of Inducible Macrophage Depletion
Goren, I., Allmann, N., Yogev, N., Schürmann, C., Linke, A., Holdener, M., Waisman, A., Pfeilschifter, J., & Frank, S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081002 · Cited by 361
Dijkgraaf, E. M., Heusinkveld, M., Tummers, B., Vogelpoel, L. T. C., Goedemans, R., Jha, V., Nortier, J. W. R., Welters, M. J. P., Kroep, J. R., & van der Burg, S. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3542 · Cited by 346 · cited 3×
“Using the chemotherapeutics agents cisplatin and carboplatin on 10 different cervical and ovarian cancer cell lines, it was shown that this induced IL-10-secreting M2 macrophages that had elevated pSTAT3 and decreased pSTAT1 and pSTAT6 [2].”
BackgroundThe role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold, L. I. (1999) · PubMed · Cited by 337
Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production
Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., & Murray, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2173 · Cited by 324 · cited 1×
“This inhibition of NO production in macrophages was found to be dependent on IL-4 or IL-13 through the depletion of Arg-1 through a Stat6-dependent pathway [38].”
BackgroundInflammatory cell infiltration of tumors: Jekyll or Hyde
Talmadge, J. E., Donkor, M., & Scholar, E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 313 · cited 1×
“The majority of intra-tumoral macrophages exhibit an M2 phenotype and are correlated with poor prognosis in a number of malignancies [86,87].”
BackgroundEffector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
Hadrup, S., Donia, M., & thor Straten, P. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0127-6 · Cited by 310 · cited 3×
“Immune checkpoints consist of a family of proteins on T-cell surfaces that interact with specific ligands on APCs or cancer cells, inhibiting TCR-mediated activation [125].”
BackgroundTumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
Kalbasi, A., Komar, C., Tooker, G. M., Liu, M., Lee, J. W., Gladney, W. L., Ben-Josef, E., & Beatty, G. L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0870 · Cited by 305 · cited 1×
“TAM recruitment is highly linked to the CCL2/CCR2 axis [52], and in many cancer models, blocking this axis has led to a significant decrease in TAM populations [53].”
BackgroundSHIP Represses the Generation of Alternatively Activated Macrophages
Rauh, M. J., Ho, V., Pereira, C., Sham, A., Sly, L. M., Lam, V., Huxham, L., Minchinton, A. I., Mui, A., & Krystal, G. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.003 · Cited by 298 · cited 1×
“SHIP−/− peritoneal and alveolar macrophages have been found to be profoundly M2-skewed, with high arginase I levels and impaired LPS-stimulated NO production [43].”
BackgroundTNF Counterbalances the Emergence of M2 Tumor Macrophages
Kratochvill, F., Neale, G., Haverkamp, J. M., Van de Velde, L.-A., Smith, A. M., Kawauchi, D., McEvoy, J., Roussel, M. F., Dyer, M. A., Qualls, J. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.033 · Cited by 277 · cited 1×
“Tumor necrosis factor receptor (TNFR) signaling was found to be a negative regulator of M2 polarization in tumor-associated macrophages (TAMs), and myeloid differentiation primary response 88 (MyD88) was shown to suppress M2 gene expression in TAMs, leading to an M1 phenotype [45].”
BackgroundRegulation of angiogenesis by a non-canonical Wnt–Flt1 pathway in myeloid cells
Stefater III, J. A., Lewkowich, I., Rao, S., Mariggi, G., Carpenter, A. C., Burr, A. R., Fan, J., Ajima, R., Molkentin, J. D., Williams, B. O., et al. (2011) · Nature · doi:10.1038/nature10085 · Cited by 274 · cited 1×
“Soluble VEGFR1 regulates the levels of VEGF so vascular complexity is reduced, and the vasculature is more properly organized [17].”
BackgroundTumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis
Jeong, H., Kim, S., Hong, B.-J., Lee, C.-J., Kim, Y.-E., Bok, S., Oh, J.-M., Gwak, S.-H., Yoo, M. Y., Lee, M. S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2545 · Cited by 268 · cited 4×
“In studies from patients with hepatocellular carcinoma (HCC), elevated levels of PDL1 expression by TAMs correlated with poorer clinical outcomes compared to patients with lower PD-L1 expression [100].”
BackgroundResultInfluentialLiu, Y., Yan, W., Tohme, S., Chen, M., Fu, Y., Tian, D., Lotze, M., Tang, D., & Tsung, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.009 · Cited by 267
The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
Thurston, G., & Daly, C. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006650 · Cited by 266
Jackute, J., Zemaitis, M., Pranys, D., Sitkauskiene, B., Miliauskas, S., Vaitkiene, S., & Sakalauskas, R. (2018) · BMC Immunology · doi:10.1186/s12865-018-0241-4 · Cited by 261 · cited 1×
“Most commonly, M1 macrophages are positively associated with longer survival times and most positive clinical outcomes in many cancers such as small cell lung cancer [79], non-small cell lung cancer [80], colorectal cancer [81], ovarian cancer [77], breast cancer [82], oral squamous cell carcinoma [83], and more.”
BackgroundTorisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000115)85:2%3c182::aid-ijc6%3e3.0.co;2-m · Cited by 254
Parker, K. H., Sinha, P., Horn, L. A., Clements, V. K., Yang, H., Li, J., Tracey, K. J., & Ostrand-Rosenberg, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2347 · Cited by 241 · cited 2×
“MDSC are elevated in most individuals with cancer and are key producers of IL-10, reducing the macrophage production of IL-12, skewing macrophages towards the M2-phenotype, and contributing to MDSC suppression [94].”
BackgroundGibbings, S. L., Goyal, R., Desch, A. N., Leach, S. M., Prabagar, M., Atif, S. M., Bratton, D. L., Janssen, W., & Jakubzick, C. V. (2015) · Blood · doi:10.1182/blood-2015-01-624809 · Cited by 240 · cited 1×
“The importance of origin in polarization is heavily debated, as hematopoietic depletion in lethal irradiation, chemotherapy, and systemic infection has shown that macrophage populations can fully return from a bone marrow-derived origin [56].”
BackgroundCytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 240
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
Brana, I., Calles, A., LoRusso, P. M., Yee, L. K., Puchalski, T. A., Seetharam, S., Zhong, B., de Boer, C. J., Tabernero, J., & Calvo, E. (2015) · Targeted Oncology · doi:10.1007/s11523-014-0320-2 · Cited by 216
The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
Susek, K. H., Karvouni, M., Alici, E., & Lundqvist, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02159 · Cited by 212 · cited 1×
“M1-like macrophages achieve this suppressing effect by recruiting CD8+ T and NK cells to the TME through antigen presentation to the T-cell receptor (TCR) [75] and the tumor-derived chemokine secretion of CXCL9, CXCL10, and CXCL11 to recruit and activate NK cells [76].”
BackgroundThe interplay between macrophages and angiogenesis in development, tissue injury and regeneration
Nucera, S., Biziato, D., & De Palma, M. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103227sn · Cited by 207 · cited 4×
“ANG2 secretion by blood vessels causes macrophages to upregulate WNT7B, which induces the proliferation of vascular endothelial cells and allows them to be targeted by ANG-2-induced apoptosis [13].”
BackgroundInfluentialM2 macrophages induce EMT through the TGF‐β/Smad2 signaling pathway
Zhu, L., Fu, X., Chen, X., Han, X., & Dong, P. (2017) · Cell Biology International · doi:10.1002/cbin.10788 · Cited by 205
TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells
Mittal, D., Saccheri, F., Vénéreau, E., Pusterla, T., Bianchi, M. E., & Rescigno, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.94 · Cited by 192 · cited 1×
“HMGB1 has been shown to be overexpressed in many solid tumors and correlated with the development of hepatocellular carcinoma [47] as well as colon [48] and skin cancers [49].”
BackgroundArgyle, D., & Kitamura, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02629 · Cited by 190
TGF-beta Signaling in Cancer Treatment
Fabregat, I., Fernando, J., Mainez, J., & Sancho, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990591 · Cited by 187
Tumor‐associated macrophages (TAMs) depend on ZEB1 for their cancer‐promoting roles
Cortés, M., Sanchez‐Moral, L., de Barrios, O., Fernández‐Aceñero, M. J., Martínez‐Campanario, M., Esteve‐Codina, A., Darling, D. S., Győrffy, B., Lawrence, T., Dean, D. C., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201797345 · Cited by 174
Fan, Z., Yu, P., Wang, Y., Wang, Y., Fu, M. L., Liu, W., Sun, Y., & Fu, Y.-X. (2006) · Blood · doi:10.1182/blood-2005-08-3485 · Cited by 170 · cited 2×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMacrophage regulation of tumor angiogenesis: Implications for cancer therapy
Squadrito, M. L., & De Palma, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.005 · Cited by 170 · cited 1×
“Macrophages have been shown to instruct functional angiogenesis in normal vessel maturation [11], wound healing [12], and development [13] and nonfunctional angiogenesis in many types of cancer [14] and chronic inflammatory conditions [15].”
BackgroundSalvagno, C., Ciampricotti, M., Tuit, S., Hau, C.-S., van Weverwijk, A., Coffelt, S. B., Kersten, K., Vrijland, K., Kos, K., Ulas, T., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0298-1 · Cited by 168
Expression of macrophage‐selective markers in human and rodent adipocytes
Khazen, W., M'Bika, J.-P., Tomkiewicz, C., Benelli, C., Chany, C., Achour, A., & Forest, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.032 · Cited by 167
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
Raggi, C., Mousa, H. S., Correnti, M., Sica, A., & Invernizzi, P. (2015) · Oncogene · doi:10.1038/onc.2015.132 · Cited by 158 · cited 1×
“Monocyte-derived macrophages that are recruited to the tumor site usually promote the proliferation and survival of tumor cells and angiogenesis [92].”
BackgroundMondini, M., Loyher, P.-L., Hamon, P., de Thoré, M. G., Laviron, M., Berthelot, K., Clémenson, C., Salomon, B. L., Combadière, C., Deutsch, É., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0633 · Cited by 154 · cited 1×
“TAM recruitment is highly linked to the CCL2/CCR2 axis [52], and in many cancer models, blocking this axis has led to a significant decrease in TAM populations [53].”
BackgroundHuber, R., Meier-Schiesser, B., Otsuka, A., Fenini, G., Satoh, T. K., Gehrke, S., Widmer, D., Levesque, M. P., Mangana, J., Kerl, K., et al. (2016) · Scientific Reports · doi:10.1038/srep29914 · Cited by 151 · cited 13×
“RAGE−/− mice did not show an upregulation of IL-10 signaling, indicating that this induction was through RAGE-dependent signaling [50].”
BackgroundInfluentialGensel, J. C., Kopper, T. J., Zhang, B., Orr, M. B., & Bailey, W. M. (2017) · Scientific Reports · doi:10.1038/srep40144 · Cited by 151
Gordon, E. J., Rao, S., Pollard, J. W., Nutt, S. L., Lang, R. A., & Harvey, N. L. (2010) · Development · doi:10.1242/dev.050021 · Cited by 146 · cited 3×
“Macrophages can promote lymphangiogenesis by transdifferentiating into lymphatic endothelial cells and becoming incorporated into growing lymphatic vessels or by secreting growth factors and proteases that lead to lymphatic vessel formation [18].”
BackgroundMacrophages and prognosis of oral squamous cell carcinoma: A systematic review
Alves, A. M., Diel, L. F., & Lamers, M. L. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12643 · Cited by 141 · cited 1×
“Most commonly, M1 macrophages are positively associated with longer survival times and most positive clinical outcomes in many cancers such as small cell lung cancer [79], non-small cell lung cancer [80], colorectal cancer [81], ovarian cancer [77], breast cancer [82], oral squamous cell carcinoma [83], and more.”
BackgroundPerivascular Macrophages Limit Permeability
He, H., Mack, J. J., Güç, E., Warren, C. M., Squadrito, M. L., Kilarski, W. W., Baer, C., Freshman, R. D., McDonald, A. I., Ziyad, S., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307592 · Cited by 138 · cited 1×
“Macrophages have been shown to instruct functional angiogenesis in normal vessel maturation [11], wound healing [12], and development [13] and nonfunctional angiogenesis in many types of cancer [14] and chronic inflammatory conditions [15].”
BackgroundCastro, B. A., Flanigan, P., Jahangiri, A., Hoffman, D., Chen, W., Kuang, R., De Lay, M., Yagnik, G., Wagner, J. R., Mascharak, S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.1 · Cited by 138
Quandt, D., Fiedler, E., Boettcher, D., Marsch, W. C., & Seliger, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2268 · Cited by 135
Xu, N., Tang, X.-H., Pan, W., Xie, Z.-M., Zhang, G.-F., Ji, M.-H., Yang, J.-J., Zhou, M.-T., & Zhou, Z.-Q. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00209 · Cited by 134 · cited 13×
“Murine M1 macrophages express macrophage receptors with collagenous structures (Marco) [23,25,26], Cxcl9, Cxcl10, Cxcl11 [23], Nos2, and Socs1, and secrete Il-6, Il-12, Il-1α [27], and Tnf-α [24], all comparable to their human counterparts.”
BackgroundInfluentialBorisenko, G. G., Matsura, T., Liu, S., Tyurin, V. A., Jiang, J., Serinkan, F. B., & Kagan, V. E. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00083-3 · Cited by 130 · cited 1×
“Phosphatidylserine is typically confined to the inner plasma membrane, but during apoptosis, it becomes externalized on the cell surface [10].”
BackgroundM1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma
Falleni, M., Savi, F., Tosi, D., Agape, E., Cerri, A., Moneghini, L., & Bulfamante, G. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000352 · Cited by 126 · cited 1×
“In the skin, during early stages of tumor development, M1 TAMs shifted to the M2 phenotype in melanoma, but the presence of either M1 or M2 TAMs was associated with poor prognosis [85].”
BackgroundObligatory participation of macrophages in an angiopoietin 2-mediated cell death switch
Rao, S., Lobov, I. B., Vallance, J. E., Tsujikawa, K., Shiojima, I., Akunuru, S., Walsh, K. X., Benjamin, L. E., & Lang, R. A. (2007) · Development · doi:10.1242/dev.012187 · Cited by 121 · cited 1×
“In response to Wnt7b, vascular endothelial cells enter the cell cycle and die in the G1 phase due to ANG2-mediated withdrawal of survival signals [16].”
BackgroundTumor Necrosis Factor-α Upregulates Angiopoietin-2 in Human Umbilical Vein Endothelial Cells
Kim, I., Kim, J.-H., Ryu, Y. S., Liu, M., & Koh, G. Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2296 · Cited by 121
Zheng, C., Yang, Q., Xu, C., Shou, P., Cao, J., Jiang, M., Chen, Q., Cao, G., Han, Y., Li, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500396113 · Cited by 121 · cited 1×
“Src homology region 2 domain-containing phosphatase 1/2 (SHP-1/2) inhibits CD11b activity, therefore inhibiting M2 polarization and leading to an increase in M1-type macrophages [42].”
BackgroundCabezas, S. C., Serafini, B., Ambrosini, E., Sanchez, M., Penna, G., Adorini, L., & Aloisi, F. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00170-4 · Cited by 116 · cited 2×
“Other cell–cell interactions induce STAT3 activation, which adds many different immunosuppressive cytokines to the TME [96].”
BackgroundExtrinsic and intrinsic control of macrophage inflammatory responses
Cohen, H. B., & Mosser, D. M. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0413236 · Cited by 114 · cited 1×
“To detail Table 2 and Figure 2, TH1 cells secrete IFN-γ, which drives polarization of macrophages towards an M1 phenotype, while TH2 cells secrete IL-4 and IL-13, which drive M2-phenotype polarization [34,37].”
BackgroundContribution of CXCL12 secretion to invasion of breast cancer cells
Boimel, P. J., Смирнова, Т. А., Zhou, Z. N., Wyckoff, J. B., Park, H., Coniglio, S. J., Qian, B., Stanley, E. R., Cox, D., Pollard, J. W., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3108 · Cited by 113
Tumor Associated Macrophages in Kidney Cancer
Kovaleva, O. V., Samoilova, D. V., Shitova, M. S., & Gratchev, A. N. (2016) · Analytical Cellular Pathology · doi:10.1155/2016/9307549 · Cited by 111 · cited 1×
“However, in some cancers such as renal cell carcinoma (RCC), several markers of M1 macrophages have been found alongside M2 markers in TAMs isolated from patients, indicating that some TAMs can exhibit a hybrid phenotype in some cancers [84].”
BackgroundRegulation of steady-state neutrophil homeostasis by macrophages
Gordy, C., Pua, H., Sempowski, G. D., & He, Y.-W. (2011) · Blood · doi:10.1182/blood-2010-01-265959 · Cited by 110 · cited 2×
“The engulfment of neutrophils and erythrocytes in the spleen and liver resolves the problems of neutropenia, splenomegaly, and reduced body weight [6].”
BackgroundLeblond, M. M., Pérès, E. A., Helaine, C., Gérault, A. N., Moulin, D., Anfray, C., Divoux, D., Petit, E., Bernaudin, M., & Valable, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19994 · Cited by 110
Zhang, J., Yan, Y., Yang, Y., Wang, L., Li, M., Wang, J., Liu, X., Duan, X., & Wang, J. (2016) · Medicine · doi:10.1097/md.0000000000002636 · Cited by 109
The Endless Saga of Monocyte Diversity
Canè, S., Ugel, S., Trovato, R., Marigo, I., Sanctis, F. D., Sartoris, S., & Bronte, V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01786 · Cited by 107
Yue, S., Rao, J., Zhu, J., Busuttil, R. W., Kupiec‐Weglinski, J. W., Lü, L., Wang, X., & Zhai, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400280 · Cited by 101 · cited 1×
“Mice with a myeloid-specific PTEN knockout have been shown to have levels of M2 macrophages and produce lower TNF-α and higher IL-10 in response to TLR ligands, indicating that PTEN plays a key role in M1 macrophage differentiation [44].”
BackgroundMacrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression
Dalton, H. J., Pradeep, S., McGuire, M., Hailemichael, Y., MA, S., Lyons, Y., Armaiz-Pena, G. N., Previs, R. A., Hansen, J. M., Rupaimoole, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0647 · Cited by 97
Tumor associated macrophages in gynecologic cancers
Krishnan, V., Schaar, B. T., Tallapragada, S., & Dorigo, O. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.01.014 · Cited by 93 · cited 6×
“While the tumor microenvironment can polarize both tissue-resident and bone marrow-derived macrophages depending on the tissue type, it is hypothesized that tissue-resident macrophages are the first to be affected [90].”
BackgroundInfluentialBipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
Gupta, V., Yull, F., & Khabele, D. (2018) · Cancers · doi:10.3390/cancers10100366 · Cited by 91
Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis
Guo, L., Cheng, X., Chen, H., Chen, C., Xie, S., Zhao, M., Liu, D., Deng, Q., Liu, Y., Wang, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.032 · Cited by 89 · cited 1×
“Most commonly, M1 macrophages are positively associated with longer survival times and most positive clinical outcomes in many cancers such as small cell lung cancer [79], non-small cell lung cancer [80], colorectal cancer [81], ovarian cancer [77], breast cancer [82], oral squamous cell carcinoma [83], and more.”
BackgroundElsawa, S. F., Novak, A. J., Ziesmer, S. C., Almada, L. L., Hodge, L. S., Grote, D. M., Witzig, T. E., Fernandez-Zapico, M. E., & Ansell, S. M. (2011) · Blood · doi:10.1182/blood-2011-04-351742 · Cited by 81
Self-citationNakamura, E. S., Koizumi, K., Kobayashi, M., & Saiki, I. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03166.x · Cited by 80
Stefanowski, J., Lang, A., Rauch, A., Aulich, L., Köhler, M., Fiedler, A. F., Buttgereit, F., Schmidt‐Bleek, K., Duda, G. N., Gaber, T., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02588 · Cited by 74 · cited 1×
“Macrophages have been shown to instruct functional angiogenesis in normal vessel maturation [11], wound healing [12], and development [13] and nonfunctional angiogenesis in many types of cancer [14] and chronic inflammatory conditions [15].”
BackgroundWang, Y., Zhang, Y., Wang, Z., Zhang, J., Qiao, R. R., Xu, M., Yang, N., Gao, L., Qiao, H., Gao, M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119378 · Cited by 70 · cited 2×
“In humans, M1 macrophages are typically identified by the surface markers CD86 and CD64 [23,24]; the macrophage receptor with collagenous structure MARCO [23,25,26]; C-XC chemokine ligand (CXCL) 9, 10, 11 (CXCL9, 10, 11) [23]; nitric oxide synthase 2 (NOS2), the suppressor of cytokine signaling 1 (SOCS1); and secretio…”
BackgroundAnderson, K. M., Czinn, S. J., Redline, R. W., & Blanchard, T. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5306 · Cited by 69 · cited 6×
“In a study of human gastric cancer patient tissue, PD-L1 and B7-H4 expression on circulating monocytes was significantly higher than normal tissue controls, and advanced stage tissues experienced higher levels of B7-H4 expression than earlier stage cancers on circulating monocytes [98].”
BackgroundInfluentialMacrophages: Good guys in colorectal cancer
Edin, S., Wikberg, M. L., Oldenborg, P., & Palmqvist, R. (2013) · OncoImmunology · doi:10.4161/onci.23038 · Cited by 68 · cited 1×
“Most commonly, M1 macrophages are positively associated with longer survival times and most positive clinical outcomes in many cancers such as small cell lung cancer [79], non-small cell lung cancer [80], colorectal cancer [81], ovarian cancer [77], breast cancer [82], oral squamous cell carcinoma [83], and more.”
BackgroundTumor‑associated macrophages in lung cancer: Friendly or evil? (Review)
Xu, F., Wei, Y., Tang, Z., Liu, B., & Dong, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11518 · Cited by 67
TIE-2 expressing monocytes in human cancers
Turrini, R., Pabois, A., Xénarios, I., Coukos, G., Delaloye, J.-F., & Doucey, M. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1303585 · Cited by 64
Maeda, A., Digifico, E., Andon, F. T., Mantovani, A., & Allavena, P. (2019) · European Journal of Immunology · doi:10.1002/eji.201847888 · Cited by 64
Zhang, Q., Mao, Z., & Sun, J. (2019) · Gene · doi:10.1016/j.gene.2019.04.039 · Cited by 62
GLI2 Transcription Factor Mediates Cytokine Cross-talk in the Tumor Microenvironment
Elsawa, S. F., Almada, L. L., Ziesmer, S. C., Novak, A. J., Witzig, T. E., Ansell, S. M., & Fernández-Zapico, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234146 · Cited by 54
Self-citationBron, S., Henry, L., Hull, E. F.-V., Turrini, R., Vanhecke, D., Guex, N., Ifticene‐Treboux, A., Iancu, E. M., Semilietof, A., Rufer, N., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1073882 · Cited by 49
Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer
Papadavid, E., Stratigos, A., & Falagas, M. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1743 · Cited by 48
Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy
Jones, D. (2020) · Cells · doi:10.3390/cells9030762 · Cited by 45
Matsunaga, T., Saito, H., & Ikeguchi, M. (2011) · Europe PMC (PubMed Central) · Cited by 29
Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer
Wang, X., Liu, Z., Sun, J., Song, X., Bian, M., Wang, F., Yan, F., & Yu, Z. (2021) · The FASEB Journal · doi:10.1096/fj.202002533r · Cited by 26 · cited 1×
“Lymphangiogenesis can lead to tumor metastasis [19], making the role of macrophage regulation important to understand and further investigate.”
BackgroundJackson, D. A., Smith, T. D., Amarsaikhan, N., Han, W., Neil, M. S., Boi, S. K., Vrabel, A. M., Tolosa, E. J., Almada, L. L., Fernández-Zapico, M. E., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402974 · Cited by 24
Self-citationGuex, N., Crespo, I., Bron, S., Ifticene‐Treboux, A., Hull, E. F.-V., Kharoubi, S., Liechti, R., Werffeli, P., Ibberson, M. R., Majo, F., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004050 · Cited by 24
松永, 知. (2011) · Institutional Repositories DataBase (IRDB) · Cited by 22
Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-α
López-González, J. S., Ávila‐Moreno, F., Prado-Garcı́a, H., Aguilar‐Cázares, D., Mandoki, J. J., & Meneses-Flores, M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.11.003 · Cited by 21 · cited 1×
“The M1 phenotype is also associated with the expression of IL-12, IL-1, and inducible nitric oxide synthase (iNOS) [77,78].”
BackgroundNovel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2
Han, W., Jackson, D. A., Matissek, S. J., Misurelli, J. A., Neil, M. S., Sklavanitis, B., Amarsaikhan, N., & Elsawa, S. F. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601490 · Cited by 21
Self-citation
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
“Nevertheless, the combination’s gene expression profiles vary from LPS and IFN-γ alone.(27) The PRRs, such as TLRs, recognize bacterial moieties.”
BackgroundRadiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Macrophage polarization: an important role in inflammatory diseases
Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 468
“Macrophages exhibit diverse morphological and functional characteristics as they undergo polarization in response to speci fi c cytokines and growth factors present in the various tissues they inhabit (188).”
BackgroundImmunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.